期刊文献+

聚乳酸防粘连膜植入联合小梁切除术治疗原发性闭角型青光眼 被引量:1

Effect of polylactic acid membrane implantation combined with trabeculectony on primary angle-closed glaucoma
下载PDF
导出
摘要 目的:探讨聚乳酸防粘连膜植入联合小梁切除术治疗原发性闭角型青光眼的疗效。方法:闭角型青光眼患者41例47眼随机分为试验组(聚乳酸防粘连膜植入联合小梁切除术)和对照组(单纯小梁切除术)。术后随访6mo,观察两组患者术后视力、眼压、滤过泡、前房等情况,并进行比较分析。结果:术后6mo试验组视力不同程度提高,眼压明显降低,和对照组比较,差异有统计学意义(P<0.05);试验组88.0%的患者形成功能性滤过泡,显著高于对照组(59.1%),差异有统计学意义(P<0.05)。结论:聚乳酸防粘连膜植入联合小梁切除术治疗原发性闭角型青光眼简单、安全、有效。 AIM: To evaluate the effect of polylactic acid membrane (PLA) implantation combined with trabeculectony on primary angle-closed glaucoma. METHODS: Totally, 41 patients(47 eyes) with primary angle-closed glaucoma were randomly divided into 2 groups. PLA implantation combined with trabeculectony was performed for the experimental group while trabeculectony for the control group. Cases were followed up for 6 months postoperatively, with observation and comparative analysis on visual acuity (VA), intraocular pressure (lOP), filtering bleb and anterior chamber depth. RESULTS: In the experimental group,6 months after the surgery, VA was improved to different degrees and lOP reduced greatly. According to comparison between the two groups, the differences were of statistic significance (P〈 0. 05). The rate of functional filtering bleb in the experimental group (88.0%) was much higher than that of the control group (59.1%, P〈0.05). CONCLUSION: PLA implantation combined with trabeculectomy for the treatment of primary angle-closed glaucoma is simple, safe and effective.
作者 李随 艾明
出处 《国际眼科杂志》 CAS 2013年第10期2114-2115,共2页 International Eye Science
关键词 聚乳酸防粘连膜植入 小梁切除术 原发性闭角型青光眼 polylactic acid membrane implantation trabeculectony primary angle-closed glaucoma
  • 相关文献

参考文献10

二级参考文献41

  • 1谢立信,曹景,董晓光,杨雪萍.环孢霉素A和地塞米松局部应用对角膜移植免疫排斥的疗效观察[J].眼科研究,1995,13(1):24-26. 被引量:8
  • 2杨君,张雪梅,刘勤.透明质酸钠在抗青光眼手术中的应用[J].眼科新进展,2006,26(5):367-368. 被引量:12
  • 3[1]Kulkarni R K. Poly ( lactic acid) for surgical implants [ J ]. Arch Surg, 1966,93:839 ~ 843
  • 4[3]Vert M. Bioresorbable polymers for temporary therapeutic applications[J]. Angew Makromol Chem, 1989,166:155 ~ 158
  • 5[4]Vert M, Schwarch G, Loudance J. Present and future of PLA polymers[J]. Pure Appl Chem, 1995,A32(4),786 ~796
  • 6[6]Apel A, Oh C, Chiu R, et al. A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy[J]. Curr Eye Res, 1995,14 (8) :659
  • 7[8]Das KG. Controlled release technology bioengineering aspects[M].New York:John Wiley and Sons,1983
  • 8[10]Yolles S,Leafe TD, Woodland JH, et al. Long acting delivery systems for narcotic antagonists Ⅱ: release rates of naltrexone from poly (lactic acid) composites [ J ]. Pharm Sci, 1975,64 ( 2 ): 348 ~ 349
  • 9[11]Eein MJ. Advance in drug delivery systems [ M ]. Am Stardam:Elsevier Sci Pub, 1987. 225 ~ 227
  • 10[12]Yamakawa I, Kawahara M, Watanabe S, et al. Sustained release of insulin by double-layered implant using poly (D, L-lactic acid )[J]. Pharm Sci, 1990,79(6) :505 ~509

共引文献42

同被引文献9

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部